Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44347 clinical trials with a EudraCT protocol, of which 7375 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,347)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

44,347 result(s) found. Displaying page 390 of 2,218.

EudraCT Number: 2017-001681-24	Sponsor Protocol Number: TAC01	Start Date*: 2017-09-27
Sponsor Name:Erasmus MC
Full Title: Avoiding tacrolimus under- and overexposure by using a new dosing algorithm for pediatric renal transplant recipients
Medical condition: kidney transplantation
Disease:
Population Age: Children, Adolescents, Under 18		Gender: Male, Female
Trial protocol: NL (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2014-000880-42

Sponsor Protocol Number: HM14/10152

Start Date*: 2014-11-12

Sponsor Name:University of Leeds

Full Title: GALACTIC: GA-101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL

Medical condition: Chronic Lymphocytic Leukaemia (CLL).

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10029104	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	SOC

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2015-002919-15

Sponsor Protocol Number: CLS001-CO-PR-004

Start Date*: 2015-11-16

Sponsor Name:Cutanea Life Sciences, Inc.

Full Title: A Phase 3, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle Administered for 12 Weeks to Subject...

Medical condition: Papulopustular rosacea

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.1	10040785 - Skin and subcutaneous tissue disorders	10039218	Rosacea	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) NL (Ongoing) SE (Completed)

Trial results: (No results available)

EudraCT Number: 2016-001045-12

Sponsor Protocol Number: NO21125

Start Date*: 2016-07-20

Sponsor Name:F. Hoffmann-La Roche AG

Full Title: A Phase II Trial of Capecitabine Rapidly Disintegrating Tablets and Concomitant Radiation Therapy in Children with Newly Diagnosed Brainstem Gliomas.

Medical condition: Intrinsic Brainstem Glioma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006143	Brain stem glioma	PT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: Outside EU/EEA

Trial results: View results

EudraCT Number: 2016-003444-37

Sponsor Protocol Number: ENTERR06929

Start Date*: 2016-08-26

Sponsor Name:Sanofi

Full Title: Bacillus clausii in the treatment of acute community–acquired diarrhea among Latin American children (cadiLAc)

Medical condition: Diarrhea

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004856	10000706	Acute diarrhea	LLT

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: Outside EU/EEA

Trial results: View results

EudraCT Number: 2016-002974-11

Sponsor Protocol Number: IBU24h-EchoG

Start Date*: 2016-11-10

Sponsor Name:María Carmen Bravo Laguna

Full Title: Phase III, randomized, multicenter, double-blind clinical trial to evaluate two echo-guided administration regimens of ibuprofen in the treatment of patent ductus arteriosus: impact on intestinal p...

Medical condition: patent ductus arteriosus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10010331 - Congenital, familial and genetic disorders	10034130	Patent ductus arteriosus	PT

Population Age: Preterm newborn infants, Under 18

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2016-004755-75	Sponsor Protocol Number: MICROPREP	Start Date*: 2017-09-28
Sponsor Name:Clinique Juge
Full Title: Intra articular injection of microfat and platelet-rich plasma in the treatment of knee osteoarthritis : a pilot study
Medical condition: knee osteoarthritis
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: FR (Ongoing)
Trial results: (No results available)

EudraCT Number: 2016-003306-13

Sponsor Protocol Number: CCR4557

Start Date*: 2017-05-16

Sponsor Name:The Royal Marsden NHS Foundation Trust

Full Title: CCR 4557: Peri-operative Immuno-Chemotherapy in Operable oesophageal aNd gastrIc Cancer (ICONIC Trial)

Medical condition: Operable oesophageal and gastric cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10062878	Gastrooesophageal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2016-002267-33

Sponsor Protocol Number: OCTO-089

Start Date*: 2017-06-13

Sponsor Name:University of Oxford

Full Title: A parallel group phase I/II marker lesion study to assess the safety, tolerability and efficacy of intravenous or intravesical pembrolizumab in intermediate risk recurrent non-muscle invasive bladd...

Medical condition: Intermediate risk recurrent non-muscle invasive bladder cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10005056	Bladder neoplasm	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2016-002474-13	Sponsor Protocol Number: 3.199	Start Date*: 2017-04-24
Sponsor Name:Innovatiefonds Zorgverzekeraars
Full Title: Medication Optimization for ADHD: MOVA study Implementation and evaluation of double-blind placebo-controlled titration in clinical practice
Medical condition: Attention Deficit Hyperactivity Disorder
Disease:
Population Age: Children, Adolescents, Under 18		Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2017-001833-15	Sponsor Protocol Number: ASLAN001-012	Start Date*: 2017-09-29
Sponsor Name:ASLAN Pharmaceuticals
Full Title: A Two-Part Phase 2/3 Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Of Varlitinib Plus mFOLFOX6 Versus Placebo Plus mFOLFOX6 in Subjects with HER1/ HER2 Co-Expressing Advanced or M...
Medical condition: HER1/ HER2 Co-Expressing Advanced or Metastatic Gastric Cancer
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: LT (Prematurely Ended) EE (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2013-005619-28

Sponsor Protocol Number: 2012.786

Start Date*: 2014-07-23

Sponsor Name:Hospices Civils de Lyon

Full Title: Influence of lipid emulsions for parenteral nutrition on the fonctional state of cutaneous barrier

Medical condition: patients avec une insuffisance intestinale chronique sévère recevant une nutrition parentérale au long cours

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	18.0	10042613 - Surgical and medical procedures	10051284	Parenteral nutrition	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: (No results available)

EudraCT Number: 2014-005612-41

Sponsor Protocol Number: 15-15

Start Date*: 2015-11-30

Sponsor Name:Meander Medical Centre

Full Title: Vitamin c to Improve Tissue healing by Administration of Multiple INtravenous dosages

Medical condition: Patients with planned revascularisation surgery on the lower extremities.

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.1	100000004848	10003451	Ascorbic acid	LLT
	18.1	10042613 - Surgical and medical procedures	10063919	Bypass surgery	LLT
	18.1	10042613 - Surgical and medical procedures	10036892	Promotion of wound healing	PT
	18.1	10042613 - Surgical and medical procedures	10061407	Vascular bypass graft	LLT
	18.1	10042613 - Surgical and medical procedures	10053375	Peripheral revascularization	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2011-005078-40	Sponsor Protocol Number: TESEC-05	Start Date*: 2016-06-03
Sponsor Name:Statens Serum Institut
Full Title: A Phase III trial in subjects suspected to have tuberculosis, comparing the diagnostic performance of C-Tb to QuantiFERON®-TB Gold In-Tube, in combination with a double blind randomised splitbody s...
Medical condition: Children (28 days–4 years old) with suspected Mycobacterium tuberculosis infection Participants between 5–65 years old who attended the TB clinic due to suspicion of TB disease (HIV positive and HI...
Disease:
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults		Gender: Male, Female
Trial protocol: Outside EU/EEA
Trial results: View results

EudraCT Number: 2015-003239-36

Sponsor Protocol Number: B9991010

Start Date*: 2016-08-22

Sponsor Name:Pfizer Inc.

Full Title: A Randomized, Open-Label, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) in Combination with and/or Following Chemotherapy in Patients with Previously Unt...

Medical condition: Epithelial ovarian cancer (EOC)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10033128	Ovarian cancer	PT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: SK (Prematurely Ended) NL (Prematurely Ended) BG (Prematurely Ended) HU (Prematurely Ended) EE (Completed) IE (Prematurely Ended) GB (Prematurely Ended) LV (Prematurely Ended) DE (Completed) PL (Prematurely Ended) HR (Completed) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2016-000084-16

Sponsor Protocol Number: NC-6004-004A

Start Date*: 2016-11-24

Sponsor Name:NanoCarrier Co, Ltd

Full Title: A Phase 1b/2 Dose Escalation and Expansion Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine in Patients with Advanced Solid Tumors or Squamous Non-Small Cell Lung, Biliary Tract, and Blad...

Medical condition: Advanced solid tumors and first-line metastatic squamous NSCLC; first-line metastatic or locally advanced cholangiocarcinoma, gallbladder cancer, or ampullary cancer (biliary tract cancer); and fir...

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10005003	Bladder cancer	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT
	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10017614	Gallbladder cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BG (Completed) PL (Completed) IT (Completed)

Trial results: (No results available)

EudraCT Number: 2016-000355-27

Sponsor Protocol Number: 995

Start Date*: 2016-03-10

Sponsor Name:University Hospitals of North Midlands NHS Trust

Full Title: The effect on Endothelial progenitor cells (EPCs) by statin loading in “all comers” with an Acute Coronary Syndrome (ACS).

Medical condition: Acute Coronary syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10007541 - Cardiac disorders	10051592	Acute coronary syndrome	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2015-005752-10

Sponsor Protocol Number: 956

Start Date*: 2016-03-11

Sponsor Name:University Hospitals of North Midlands NHS Trust

Full Title: The relationship between computerised tomographic coronary angiography (CTCA) calcium scoring and endothelial progenitor cell (EPC) count. Study A and B.

Medical condition: Coronary Artery Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	10007541 - Cardiac disorders	10011078	Coronary artery disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2016-003940-35

Sponsor Protocol Number: KF6010-02

Start Date*: 2017-05-22

Sponsor Name:Grünenthal GmbH

Full Title: Exploratory, randomized, double-blind, placebo-controlled evaluation of efficacy, tolerability, and safety of intravesical instillation of GRT6010 compared to placebo in subjects with bladder pain ...

Medical condition: Bladder pain syndrome.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.1	100000004857	10071166	Bladder pain syndrome	LLT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DE (Completed) PL (Completed)

Trial results: View results

EudraCT Number: 2016-003686-26

Sponsor Protocol Number: M16-300

Start Date*: 2017-08-28

Sponsor Name:AbbVie Stemcentrx LLC

Full Title: A Phase 1/2 Study on the Safety of Rovalpituzumab Tesirine Administered in Combination with Nivolumab or Nivolumab and Ipilimumab for Adults with Extensive-Stage Small Cell Lung Cancer

Medical condition: Extensive-Stage Small Cell Lung Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10041068	Small cell lung cancer extensive stage	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) ES (Completed) IT (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Sat Jul 05 07:32:09 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA